Delighted to be able to say that today I have been promoted to Professor of Medical Microbiology at Norwich Medical School @uniofeastanglia. 🥳

This week, the @WHO announced its support of the use @nanopore's rapid test (in development) for profiling drug-resistant tuberculosis — a significant milestone in the fight against one of the most persistent threats in public health globally. bit.ly/3rJVJHy 🧵 1/5

🆕A rapid test in development by Oxford @nanopore in collaboration with the Quadram Institute is one of three sequencing-based tests for TB supported by WHO in a significant step in the global fight against infectious disease 🧬

Read more ➡️ buff.ly/3q9fgkf

Secretary of State @NorwichChloe visited @nanopore to discover how their technology is already improving patient care.

Today’s life science's announcements demonstrate our dedication to enhance people's lives and the economy by funding this important sector.

Today @nanopore & @biomerieux, global leader in in vitro diagnostics, announce a new partnership to bring nanopore sequencing to the infectious disease diagnostics market: nanoporetech.com/about-us/news/… 1 /3

We are excited to enter into a research partnership with Oxford Nanopore in the field of infectious diseases. New technologies such as sequencing hold promise to improve diagnostics and patient care; our teams will collaborate in this direction. businesswire.com/news/home/2023…

At @rhodes_trust Policy Summit today discussing “always on” pandemic preparedness
rhodeshouse.ox.ac.uk/news-events/ev…
@nanopore genomic surveillance is a “game changer” for health systems @JustinOGrady

The customer workflows team @nanopore is still growing to help us deliver ISO accredited bioinformatics workflows for clinical applications. It's a really exciting time - help define our processes and build robust workflows. #bioinformatics #gemonics

ejnh.fa.em2.oraclecloud.com/hcmUI/Candidat…

Targeted genomic sequencing needed for rapid detection of DR-TB
indianexpress.com/article/cities…
@BjgmcSgh
@r_karyakarte
@Justin_OGrady

What is resistance in M. tuberculosis? New data on this from our large collaborative study linking WGS and MICs just published in Lancet Microbe @FZBorstel @SRLBorstel @DZIF_ @medinflame @trans_evo @merker_matthias @cdenki
sciencedirect.com/science/articl…

Last week @TheLancet published findings from the 2015 European Burden of Disease study, finding 70% of all DALYs were caused by four antibiotic-resistant bacteria. The paper advocates for #AMR stewardship and greater infection prevention

Read more buff.ly/3BZYrvR

Useful update to the H37Rv reference genome for anyone handling M. tuberculosis sequence data #TB

Great work from @MadsAlbertsen85 and colleagues assessing metagenomic assembly quality across DNA sequencing technologies (nature.com/articles/s4159…) it looks like @nanopore R10.4 no longer needs polishing with illumina (at least for bacteria) on both mock and real samples.

Two long read capable #NGS technologies compared side by side.

The winner of this year’s Best Newcomer Award, sponsored by @co_garnier is… @nanopore. Huge congratulations on your very well deserved win! #winner #newcomer #MediscienceAwards

Wow, what an #ESHG2022 talk!

#CRISPR-Cas9 causes off target structural variants in zebrafish
NOT detected by short-read sequencing and ARE passed on to offspring.

Huge implications to studies and any possible future therapeutic editing

Paper is here:
nature.com/articles/s4146…

Good morning #Tbilisi , what a beautiful city! Over here to set up our drug resistant tuberculosis assay at the National Tuberculosis Centre

The gaf looks ok too, if your into that kind of thing

You probably have a few quid when this is what the stables looks like! @ChatsworthHouse

WHO just published for the first time CONSOLIDATED guidelines on drug-susceptible #TB, also including a new recommendation on the use of a 4-month rifapentine-containing regimen (HPMZ) -- another first for TB! createsend.com/t/d-D008EFE5E3…

Nice to be back at London Calling in person @nanopore #NanoporeConf